Mercaptopurine
AlkaPlorer ID: AK001572
Synonym: None
IUPAC Name: 3,7-dihydropurine-6-thione
Structure
SMILES: SC1=NC=NC2=C1N=CN2
InChI: InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)
InChIKey: GLVAUDGFNGKCSF-UHFFFAOYSA-N
Reference
Phenylethanoid Glycosides from <i>Lantana fucata</i> with <i>in Vitro</i> Anti-inflammatory Activity
PubChem CID: 667490
CAS: 1194-62-3
LOTUS: LTS0233990
COCONUT: CNP0166130
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| Origanum dictamnus | Origanum | Lamiaceae | Lamiales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
Properties Information
Molecule Weight: 152.18200000000002
TPSA?: 54.46
MolLogP?: 0.6416
Number of H-Donors: 2
Number of H-Acceptors: 4
RingCount: 2
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | 19.41 | % | 10.6019/CHEMBL4513141 |
| Agaricus bisporus | Tyrosinase | Ki | 16000.0 | nM | 10.1016/j.ejmech.2020.112275 |
| Bacillus anthracis | Bacillus anthracis | IC50 | 400000.0 | nM | 10.1128/aac.01029-10 |
| Bacillus anthracis | Bacillus anthracis | IC50 | nan | None | 10.1128/aac.01029-10 |
| Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Potency | 39810.7 | nM | None |
| Bos taurus | Progesterone receptor | IC50 | nan | None | None |
| Bos taurus | Progesterone receptor | Ki | nan | None | None |
| Candida albicans | Candida albicans | Inhibition | 11.25 | % | 10.6019/CHEMBL4513141 |
| Cavia porcellus | Leukotriene C4 synthase | IC50 | nan | None | None |
| Cavia porcellus | Leukotriene C4 synthase | Ki | nan | None | None |
| Cavia porcellus | Serotonin 4 (5-HT4) receptor | IC50 | nan | None | None |
| Cavia porcellus | Serotonin 4 (5-HT4) receptor | Ki | nan | None | None |
| Chikungunya virus | Chikungunya virus | Activity | 47.0 | U/ml | 10.1016/j.bmc.2017.06.049 |
| Chlorocebus sabaeus | Vero | IC50 | 67500.0 | nM | 10.1021/np900047p |
| Chlorocebus sabaeus | Vero | IC50 | 67600.0 | nM | 10.1016/j.ejmech.2012.05.032 |
| Chlorocebus sabaeus | Vero | IC50 | 67600.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Chlorocebus sabaeus | Vero | IC50 | 117000.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Chlorocebus sabaeus | Vero | IC50 | 118600.0 | nM | 10.1021/np900047p |
| Chlorocebus sabaeus | Vero | Ratio IC50 | 48.3 | None | 10.1016/j.ejmech.2012.05.032 |
| Cricetulus griseus | CHO | ED50 | 50.0 | uM | 10.1021/ml300227d |
| Cricetulus griseus | CHO | Log CR | -0.3 | None | 10.1021/jm00169a014 |
| Cricetulus griseus | CHO | Potency | 7079.5 | nM | None |
| Cricetulus griseus | CHO | Potency | 7943.3 | nM | None |
| Cryptococcus neoformans | Cryptococcus neoformans | Inhibition | -0.87 | % | 10.6019/CHEMBL4513141 |
| Eimeria tenella | Eimeria tenella | MEC | 20.0 | mg l-1 | 10.1021/jm00343a007 |
| Enterococcus faecalis | Enterococcus faecalis | Activity | 128.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Escherichia coli | Escherichia coli | Activity | 128.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Escherichia coli | Escherichia coli | Inhibition | 6.85 | % | 10.6019/CHEMBL4513141 |
| Escherichia coli K-12 | Beta-lactamase AmpC | Potency | 35481.3 | nM | None |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 5610.1 | nM | None |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 7943.3 | nM | None |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 39810.7 | nM | None |
| Helicobacter pylori | Helicobacter pylori | Activity | nan | None | 10.1021/acs.jmedchem.0c02184 |
| Homo sapiens | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Potency | 28183.8 | nM | None |
| Homo sapiens | 786-0 | GI50 | 2027.68 | nM | None |
| Homo sapiens | A498 | GI50 | 58748.94 | nM | None |
| Homo sapiens | A549 | GI50 | 30130.06 | nM | None |
| Homo sapiens | A549 | IC50 | 47000.0 | nM | 10.1016/j.ejmech.2012.05.032 |
| Homo sapiens | A549 | IC50 | 47000.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Homo sapiens | A549 | IC50 | 47000.0 | nM | 10.1021/np900047p |
| Homo sapiens | A549 | IC50 | 49300.0 | nM | 10.1021/np900047p |
| Homo sapiens | A549 | IC50 | 49400.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Homo sapiens | Acetylcholinesterase | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Acetylcholinesterase | IC50 | nan | None | None |
| Homo sapiens | Acetylcholinesterase | Ki | nan | None | None |
| Homo sapiens | ACHN | GI50 | 6266.14 | nM | None |
| Homo sapiens | Adenosine A1 receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A1 receptor | Ki | nan | None | None |
| Homo sapiens | Adenosine A2a receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A2a receptor | Ki | nan | None | None |
| Homo sapiens | Adenosine A3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Adenosine A3 receptor | IC50 | nan | None | None |
| Homo sapiens | Adenosine A3 receptor | Ki | nan | None | None |
| Homo sapiens | Aldehyde dehydrogenase 1A1 | Potency | 7943.3 | nM | None |
| Homo sapiens | Alpha-1a adrenergic receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-1d adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-1d adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Alpha-2a adrenergic receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2a adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-2a adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Alpha-2b adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-2b adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Alpha-2c adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Alpha-2c adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Androgen Receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | IC50 | nan | None | None |
| Homo sapiens | Angiotensin II type 2 (AT-2) receptor | Ki | nan | None | None |
| Homo sapiens | Ataxin-2 | Potency | 3548.1 | nM | None |
| Homo sapiens | Beta-1 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-1 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Beta-2 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-2 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Beta-3 adrenergic receptor | IC50 | nan | None | None |
| Homo sapiens | Beta-3 adrenergic receptor | Ki | nan | None | None |
| Homo sapiens | Bile salt export pump | AC50 | 300000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Bile salt export pump | IC50 | 133000.0 | nM | 10.1093/toxsci/kft176 |
| Homo sapiens | BJ | EC50 | 4326.0 | nM | None |
| Homo sapiens | BJ | EC50 | 133300.0 | nM | None |
| Homo sapiens | BJ | EC50 | 150000.0 | nM | None |
| Homo sapiens | Bradykinin B2 receptor | IC50 | nan | None | None |
| Homo sapiens | Bradykinin B2 receptor | Ki | nan | None | None |
| Homo sapiens | Bromodomain adjacent to zinc finger domain protein 2B | Potency | 50118.7 | nM | None |
| Homo sapiens | BT-549 | GI50 | 100230.52 | nM | None |
| Homo sapiens | CAKI-1 | GI50 | 3213.66 | nM | None |
| Homo sapiens | Calcitonin receptor | IC50 | nan | None | None |
| Homo sapiens | Calcitonin receptor | Ki | nan | None | None |
| Homo sapiens | Canalicular multispecific organic anion transporter 1 | IC50 | nan | None | 10.1093/toxsci/kft176 |
| Homo sapiens | Canalicular multispecific organic anion transporter 2 | IC50 | nan | None | 10.1093/toxsci/kft176 |
| Homo sapiens | Cannabinoid CB1 receptor | IC50 | nan | None | None |
| Homo sapiens | Cannabinoid CB1 receptor | Ki | nan | None | None |
| Homo sapiens | Carbonic anhydrase II | IC50 | nan | None | None |
| Homo sapiens | Carbonic anhydrase II | Ki | nan | None | None |
| Homo sapiens | Caspase-1 | IC50 | nan | None | None |
| Homo sapiens | Caspase-1 | Ki | nan | None | None |
| Homo sapiens | Cathepsin G | IC50 | nan | None | None |
| Homo sapiens | Cathepsin G | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 2 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 2 | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 4 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 4 | Ki | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 5 | IC50 | nan | None | None |
| Homo sapiens | C-C chemokine receptor type 5 | Ki | nan | None | None |
| Homo sapiens | CCRF-CEM | CC50 | 1000.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | CCRF-CEM | GI50 | 1264.74 | nM | None |
| Homo sapiens | CCRF-CEM | IC50 | 1000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | CCRF-SB | CC50 | 1100.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | CCRF-SB | IC50 | 1000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 7943.3 | nM | None |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 10000.0 | nM | None |
| Homo sapiens | Cholecystokinin A receptor | IC50 | nan | None | None |
| Homo sapiens | Cholecystokinin A receptor | Ki | nan | None | None |
| Homo sapiens | COLO 205 | GI50 | 4943.11 | nM | None |
| Homo sapiens | Cyclooxygenase-1 | AC50 | 14623.1 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cyclooxygenase-1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cyclooxygenase-1 | IC50 | 16242.0 | nM | None |
| Homo sapiens | Cyclooxygenase-1 | Ki | nan | None | None |
| Homo sapiens | Cyclooxygenase-2 | IC50 | nan | None | None |
| Homo sapiens | Cyclooxygenase-2 | Ki | nan | None | None |
| Homo sapiens | Cysteinyl leukotriene receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Cysteinyl leukotriene receptor 1 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 1A2 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 1A2 | Inhibition | nan | % | 10.1021/tx300075j |
| Homo sapiens | Cytochrome P450 1A2 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2A6 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2A6 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | Inhibition | nan | % | 10.1021/tx300075j |
| Homo sapiens | Cytochrome P450 2C19 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | Inhibition | nan | % | 10.1021/tx300075j |
| Homo sapiens | Cytochrome P450 2C9 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | FC | 1.0 | None | 10.1016/j.bmcl.2016.06.088 |
| Homo sapiens | Cytochrome P450 2D6 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | Inhibition | nan | % | 10.1021/tx300075j |
| Homo sapiens | Cytochrome P450 2D6 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 2E1 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2E1 | Ki | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | FC | 1.0 | None | 10.1016/j.bmcl.2016.06.088 |
| Homo sapiens | Cytochrome P450 3A4 | IC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | Inhibition | nan | % | 10.1021/tx300075j |
| Homo sapiens | Cytochrome P450 3A4 | Ki | nan | None | None |
| Homo sapiens | DAN-G | IC50 | 4060.0 | nM | 10.1124/dmd.110.033613 |
| Homo sapiens | Daudi | Activity | nan | None | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | Daudi | IC50 | 200000.0 | nM | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | Delta opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Delta opioid receptor | Ki | nan | None | None |
| Homo sapiens | DLD-1 | GI50 | 2079.7 | nM | None |
| Homo sapiens | DMS-114 | GI50 | 1674.94 | nM | None |
| Homo sapiens | DMS-273 | GI50 | 425.6 | nM | None |
| Homo sapiens | Dopamine D1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D1 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D1 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D2 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D2 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D3 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D3 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine D4 receptor | IC50 | nan | None | None |
| Homo sapiens | Dopamine D4 receptor | Ki | nan | None | None |
| Homo sapiens | Dopamine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine transporter | IC50 | nan | None | None |
| Homo sapiens | Dopamine transporter | Ki | nan | None | None |
| Homo sapiens | DU-145 | CC50 | 2000.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | DU-145 | GI50 | 2506.11 | nM | None |
| Homo sapiens | DU-145 | IC50 | 2000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | EKVX | GI50 | 263026.8 | nM | None |
| Homo sapiens | Endothelin receptor ET-A | IC50 | nan | None | None |
| Homo sapiens | Endothelin receptor ET-A | Ki | nan | None | None |
| Homo sapiens | Epidermal growth factor receptor erbB1 | IC50 | nan | None | None |
| Homo sapiens | Epidermal growth factor receptor erbB1 | Ki | nan | None | None |
| Homo sapiens | Estrogen receptor alpha | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Estrogen receptor alpha | IC50 | nan | None | None |
| Homo sapiens | Estrogen receptor alpha | Ki | nan | None | None |
| Homo sapiens | Estrogen receptor beta | IC50 | nan | None | None |
| Homo sapiens | Estrogen receptor beta | Ki | nan | None | None |
| Homo sapiens | Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Glucocorticoid receptor | IC50 | nan | None | None |
| Homo sapiens | Glucocorticoid receptor | Ki | nan | None | None |
| Homo sapiens | HCC 2998 | GI50 | 3507.52 | nM | None |
| Homo sapiens | HCT-116 | GI50 | 2365.92 | nM | None |
| Homo sapiens | HCT-15 | GI50 | 4570.88 | nM | None |
| Homo sapiens | HEK293 | IC50 | 0.00071 | ug.mL-1 | 10.1021/np800610p |
| Homo sapiens | HEK293 | IC50 | 7.0 | nM | 10.1021/np050493r |
| Homo sapiens | HEK293 | IC50 | 7.0 | nM | 10.1021/np060257w |
| Homo sapiens | HEK293 | IC50 | 7.0 | nM | 10.1021/np8000464 |
| Homo sapiens | HEK293 | IC50 | 7.0 | nM | 10.1021/np990231n |
| Homo sapiens | HeLa | Activity | 75.0 | % | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | HeLa | Activity | nan | None | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | HeLa | ED50 | 0.1 | ug ml-1 | 10.1021/jm00191a007 |
| Homo sapiens | HeLa | ED50 | 0.1 | ug ml-1 | 10.1021/jm00193a011 |
| Homo sapiens | HeLa | ED50 | 0.1 | ug ml-1 | 10.1021/jm00204a014 |
| Homo sapiens | HeLa | IC50 | 2900.0 | nM | 10.1016/j.ejmech.2012.05.032 |
| Homo sapiens | HeLa | IC50 | 2900.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Homo sapiens | HeLa | IC50 | 2900.0 | nM | 10.1021/np900047p |
| Homo sapiens | HeLa | IC50 | 4100.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Homo sapiens | HeLa | IC50 | 4100.0 | nM | 10.1021/np900047p |
| Homo sapiens | HeLa | IC50 | 200000.0 | nM | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | Hemoglobin beta chain | Potency | 3162.3 | nM | None |
| Homo sapiens | Hemoglobin beta chain | Potency | 6309.6 | nM | None |
| Homo sapiens | HEp-2 | IC50 | 317800.0 | nM | 10.1021/np900047p |
| Homo sapiens | HEp-2 | IC50 | 431000.0 | nM | 10.1021/np900047p |
| Homo sapiens | HepG2 | CC50 | 8000.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | HepG2 | IC50 | 8000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | HepG2 | Potency | 3162.3 | nM | None |
| Homo sapiens | HERG | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | HERG | IC50 | nan | None | None |
| Homo sapiens | HERG | Ki | nan | None | None |
| Homo sapiens | Histamine H1 receptor | IC50 | nan | None | None |
| Homo sapiens | Histamine H1 receptor | Ki | nan | None | None |
| Homo sapiens | Histamine H2 receptor | IC50 | nan | None | None |
| Homo sapiens | Histamine H2 receptor | Ki | nan | None | None |
| Homo sapiens | Histamine H3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histone acetyltransferase GCN5 | Potency | 39810.7 | nM | None |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -30.05 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 0.77 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 7079.5 | nM | None |
| Homo sapiens | HL-60 | GI50 | 2437.81 | nM | None |
| Homo sapiens | HMG-CoA reductase | IC50 | nan | None | None |
| Homo sapiens | HMG-CoA reductase | Ki | nan | None | None |
| Homo sapiens | Homo sapiens | Activity | 2.0 | % | 10.1136/gut.39.1.63 |
| Homo sapiens | Homo sapiens | CL | 15.0 | mL.min-1.kg-1 | 10.1021/jm900403j |
| Homo sapiens | Homo sapiens | CL_renal | 0.68 | mL.min-1.kg-1 | 10.1021/jm900403j |
| Homo sapiens | Homo sapiens | Cmax | 131.42 | nM | None |
| Homo sapiens | Homo sapiens | DILI_Concern | nan | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | Homo sapiens | DILI_severity_class | 8.0 | None | 10.1016/j.drudis.2016.02.015 |
| Homo sapiens | Homo sapiens | F | 60.0 | % | None |
| Homo sapiens | Homo sapiens | Tmax | 1.0 | hr | None |
| Homo sapiens | HOP-18 | GI50 | 191866.87 | nM | None |
| Homo sapiens | HOP-62 | GI50 | 1749.85 | nM | None |
| Homo sapiens | HOP-92 | GI50 | 2944.42 | nM | None |
| Homo sapiens | Hs-578T | GI50 | 14157.94 | nM | None |
| Homo sapiens | HT-29 | Activity | nan | None | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | HT-29 | GI50 | 4017.91 | nM | None |
| Homo sapiens | HT-29 | IC50 | 0.87 | ug.mL-1 | 10.1021/np50112a002 |
| Homo sapiens | HT-29 | IC50 | 200000.0 | nM | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | Hypoxanthine-guanine phosphoribosyltransferase | Km | 1150.0 | nM | 10.1021/jm061012j |
| Homo sapiens | Hypoxanthine-guanine phosphoribosyltransferase | Km | 3000.0 | nM | 10.1021/jm061012j |
| Homo sapiens | IGR-1 | IC50 | 1.1 | ug.mL-1 | 10.1021/np960657r |
| Homo sapiens | IGR-1 | IC50 | 12.3 | ug.mL-1 | 10.1021/np960657r |
| Homo sapiens | IGR-1 | IC50 | 51.7 | ug.mL-1 | 10.1021/np960657r |
| Homo sapiens | IGROV-1 | GI50 | 9484.18 | nM | None |
| Homo sapiens | Indoleamine 2,3-dioxygenase | IC50 | nan | None | 10.1016/j.ejmech.2014.06.078 |
| Homo sapiens | Indoleamine 2,3-dioxygenase | Inhibition | 0.5 | % | 10.1016/j.ejmech.2014.06.078 |
| Homo sapiens | Interleukin-8 receptor A | IC50 | nan | None | None |
| Homo sapiens | Interleukin-8 receptor A | Ki | nan | None | None |
| Homo sapiens | Interleukin-8 receptor B | IC50 | nan | None | None |
| Homo sapiens | Interleukin-8 receptor B | Ki | nan | None | None |
| Homo sapiens | Isocitrate dehydrogenase [NADP] cytoplasmic | Potency | 2592.9 | nM | None |
| Homo sapiens | Jurkat | IC50 | 200000.0 | nM | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | K562 | GI50 | 350.75 | nM | None |
| Homo sapiens | K562 | IC50 | 0.4 | ug.mL-1 | 10.1016/s0960-894x(01)00803-4 |
| Homo sapiens | K562 | IC50 | 0.6 | ug.mL-1 | 10.1016/s0960-894x(03)00011-8 |
| Homo sapiens | K562 | IC50 | 8.5 | ug.mL-1 | 10.1016/s0960-894x(01)00803-4 |
| Homo sapiens | K562 | IC50 | 10.0 | ug.mL-1 | 10.1016/s0960-894x(03)00011-8 |
| Homo sapiens | K562 | Inhibition | 80.0 | % | 10.1016/s0960-894x(03)00011-8 |
| Homo sapiens | Kappa opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Kappa opioid receptor | Ki | nan | None | None |
| Homo sapiens | KB | ED50 | 0.1 | ug ml-1 | 10.1021/jm00204a014 |
| Homo sapiens | KB | ED50 | 0.54 | ug ml-1 | 10.1021/np50100a013 |
| Homo sapiens | KB | IC50 | 0.55 | ug.mL-1 | 10.1021/np50112a002 |
| Homo sapiens | KM12 | GI50 | 7568.33 | nM | None |
| Homo sapiens | KM-20L2 | GI50 | 1923.09 | nM | None |
| Homo sapiens | Leukocyte common antigen | IC50 | nan | None | None |
| Homo sapiens | Leukocyte common antigen | Ki | nan | None | None |
| Homo sapiens | Leukocyte elastase | IC50 | nan | None | None |
| Homo sapiens | Leukocyte elastase | Ki | nan | None | None |
| Homo sapiens | Liver microsomes | Activity | nan | None | 10.1021/tx300075j |
| Homo sapiens | Liver microsomes | Stability | nan | % | 10.1021/tx300075j |
| Homo sapiens | LOX IMVI | GI50 | 382.82 | nM | None |
| Homo sapiens | LXFL 529 | GI50 | 653130.55 | nM | None |
| Homo sapiens | Lysine-specific demethylase 4A | Potency | 6309.6 | nM | None |
| Homo sapiens | Lysine-specific demethylase 4D-like | Potency | 19952.6 | nM | None |
| Homo sapiens | M14 | GI50 | 674.53 | nM | None |
| Homo sapiens | M19-MEL | GI50 | 69023.98 | nM | None |
| Homo sapiens | Malme-3M | GI50 | 3664.38 | nM | None |
| Homo sapiens | MAP kinase ERK1 | IC50 | nan | None | None |
| Homo sapiens | MAP kinase ERK1 | Ki | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | IC50 | nan | None | None |
| Homo sapiens | MAP kinase ERK2 | Ki | nan | None | None |
| Homo sapiens | MAP kinase p38 alpha | IC50 | nan | None | None |
| Homo sapiens | MAP kinase p38 alpha | Ki | nan | None | None |
| Homo sapiens | Matrix metalloproteinase-1 | IC50 | nan | None | None |
| Homo sapiens | Matrix metalloproteinase-1 | Ki | nan | None | None |
| Homo sapiens | Matrix metalloproteinase 9 | IC50 | nan | None | None |
| Homo sapiens | Matrix metalloproteinase 9 | Ki | nan | None | None |
| Homo sapiens | MCF7 | CC50 | 3200.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | MCF7 | GI50 | 1644.37 | nM | None |
| Homo sapiens | MCF7 | IC50 | 1400.0 | nM | 10.1016/j.ejmech.2012.05.032 |
| Homo sapiens | MCF7 | IC50 | 1400.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Homo sapiens | MCF7 | IC50 | 1400.0 | nM | 10.1021/np900047p |
| Homo sapiens | MCF7 | IC50 | 2790.0 | nM | 10.1021/ml300227d |
| Homo sapiens | MCF7 | IC50 | 3000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | MCF7 | IC50 | 5800.0 | nM | 10.1016/j.ejmech.2017.09.004 |
| Homo sapiens | MCF7 | IC50 | 5800.0 | nM | 10.1021/np900047p |
| Homo sapiens | MDA-MB-231 | GI50 | 24434.31 | nM | None |
| Homo sapiens | MDA-MB-435 | GI50 | 1435.49 | nM | None |
| Homo sapiens | MDA-N | GI50 | 1782.38 | nM | None |
| Homo sapiens | Melanocortin receptor 3 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 3 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 4 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 4 | Ki | nan | None | None |
| Homo sapiens | Melanocortin receptor 5 | IC50 | nan | None | None |
| Homo sapiens | Melanocortin receptor 5 | Ki | nan | None | None |
| Homo sapiens | MOLT-4 | GI50 | 1614.36 | nM | None |
| Homo sapiens | MOLT-4 | IC50 | 50500.0 | nM | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | Monoamine oxidase A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Monoamine oxidase A | IC50 | nan | None | None |
| Homo sapiens | Monoamine oxidase A | Ki | nan | None | None |
| Homo sapiens | MT4 | CC50 | 100.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | MT4 | IC50 | 100.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | Multidrug resistance-associated protein 4 | Activity | nan | None | 10.1074/jbc.m104833200 |
| Homo sapiens | Multidrug resistance-associated protein 4 | IC50 | nan | None | 10.1093/toxsci/kft176 |
| Homo sapiens | Multidrug resistance-associated protein 5 | Activity | nan | None | 10.1073/pnas.120159197 |
| Homo sapiens | Mu opioid receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Mu opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Mu opioid receptor | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M3 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M4 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M4 | Ki | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M5 | IC50 | nan | None | None |
| Homo sapiens | Muscarinic acetylcholine receptor M5 | Ki | nan | None | None |
| Homo sapiens | NCI/ADR-RES | GI50 | 3556.31 | nM | None |
| Homo sapiens | NCI-H226 | GI50 | 58479.01 | nM | None |
| Homo sapiens | NCI-H23 | GI50 | 3890.45 | nM | None |
| Homo sapiens | NCI-H322M | GI50 | 9462.37 | nM | None |
| Homo sapiens | NCI-H460 | GI50 | 5533.5 | nM | None |
| Homo sapiens | NCI-H522 | GI50 | 1618.08 | nM | None |
| Homo sapiens | NCI-N87 | Activity | 80.0 | % | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | NCI-N87 | Activity | nan | None | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | Neurokinin 1 receptor | IC50 | nan | None | None |
| Homo sapiens | Neurokinin 1 receptor | Ki | nan | None | None |
| Homo sapiens | Neurokinin 2 receptor | IC50 | nan | None | None |
| Homo sapiens | Neurokinin 2 receptor | Ki | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 1 | IC50 | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 1 | Ki | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 2 | IC50 | nan | None | None |
| Homo sapiens | Neuropeptide Y receptor type 2 | Ki | nan | None | None |
| Homo sapiens | Norepinephrine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Norepinephrine transporter | IC50 | nan | None | None |
| Homo sapiens | Norepinephrine transporter | Ki | nan | None | None |
| Homo sapiens | OVCAR-3 | GI50 | 857.04 | nM | None |
| Homo sapiens | OVCAR-4 | GI50 | 8053.78 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 8629.79 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 2540.97 | nM | None |
| Homo sapiens | PBMC | IC50 | 149.5 | nM | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | PC-3 | GI50 | 4385.31 | nM | None |
| Homo sapiens | Phosphodiesterase 3A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 4A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 5A | IC50 | nan | None | None |
| Homo sapiens | Phosphodiesterase 5A | Ki | nan | None | None |
| Homo sapiens | Platelet activating factor receptor | IC50 | nan | None | None |
| Homo sapiens | Platelet activating factor receptor | Ki | nan | None | None |
| Homo sapiens | Progesterone receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Protein kinase C alpha | IC50 | nan | None | None |
| Homo sapiens | Protein kinase C alpha | Ki | nan | None | None |
| Homo sapiens | Receptor protein-tyrosine kinase erbB-2 | IC50 | nan | None | None |
| Homo sapiens | Receptor protein-tyrosine kinase erbB-2 | Ki | nan | None | None |
| Homo sapiens | REH | IC50 | 2940.0 | nM | 10.1039/C8MD00463C |
| Homo sapiens | RPMI-8226 | GI50 | 1757.92 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 29512.09 | nM | None |
| Homo sapiens | RXF 631 | GI50 | 10423.17 | nM | None |
| Homo sapiens | Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform | IC50 | nan | None | None |
| Homo sapiens | Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform | Ki | nan | None | None |
| Homo sapiens | Serotonin 1a (5-HT1a) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2a (5-HT2a) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 2c (5-HT2c) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin 6 (5-HT6) receptor | IC50 | nan | None | None |
| Homo sapiens | Serotonin 6 (5-HT6) receptor | Ki | nan | None | None |
| Homo sapiens | Serotonin transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin transporter | IC50 | nan | None | None |
| Homo sapiens | Serotonin transporter | Ki | nan | None | None |
| Homo sapiens | SF-268 | GI50 | 4111.5 | nM | None |
| Homo sapiens | SF-295 | GI50 | 5807.64 | nM | None |
| Homo sapiens | SF-539 | GI50 | 2488.86 | nM | None |
| Homo sapiens | Sigma opioid receptor | IC50 | nan | None | None |
| Homo sapiens | Sigma opioid receptor | Ki | nan | None | None |
| Homo sapiens | SK-MEL-2 | GI50 | 5970.35 | nM | None |
| Homo sapiens | SK-MEL-28 | CC50 | 15000.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | SK-MEL-28 | GI50 | 372391.71 | nM | None |
| Homo sapiens | SK-MEL-28 | IC50 | 15000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | SK-MEL-5 | GI50 | 8356.03 | nM | None |
| Homo sapiens | SK-MES-1 | CC50 | 58000.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | SK-MES-1 | IC50 | 58000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | SK-OV-3 | GI50 | 1030.39 | nM | None |
| Homo sapiens | SN12C | GI50 | 23823.19 | nM | None |
| Homo sapiens | SN12K1 | GI50 | 1294.2 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 127643.88 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 8749.84 | nM | None |
| Homo sapiens | SNB-78 | GI50 | 90364.95 | nM | None |
| Homo sapiens | Solute carrier organic anion transporter family member 1B1 | Inhibition | 107.78 | % | 10.1124/mol.112.084152 |
| Homo sapiens | Solute carrier organic anion transporter family member 1B3 | Inhibition | 105.34 | % | 10.1124/mol.112.084152 |
| Homo sapiens | SR | GI50 | 1241.65 | nM | None |
| Homo sapiens | Survival motor neuron protein | Potency | 4466.8 | nM | None |
| Homo sapiens | SW-620 | GI50 | 6382.63 | nM | None |
| Homo sapiens | T47D | GI50 | 3548.13 | nM | None |
| Homo sapiens | Thrombin | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Thromboxane A2 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Thromboxane-A synthase | IC50 | nan | None | None |
| Homo sapiens | Thromboxane-A synthase | Ki | nan | None | None |
| Homo sapiens | TK-10 | GI50 | 1940.89 | nM | None |
| Homo sapiens | Transcriptional regulator ERG | Potency | 11220.2 | nM | None |
| Homo sapiens | Tyrosine-protein kinase FYN | IC50 | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase FYN | Ki | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase LCK | IC50 | nan | None | None |
| Homo sapiens | Tyrosine-protein kinase LCK | Ki | nan | None | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 6513.1 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 12995.3 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 18837.5 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 29855.4 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 31622.8 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 39810.7 | nM | None |
| Homo sapiens | U-251 | GI50 | 13740.42 | nM | None |
| Homo sapiens | U-937 | IC50 | 200000.0 | nM | 10.1016/j.ejmech.2008.03.027 |
| Homo sapiens | UACC-257 | GI50 | 14354.89 | nM | None |
| Homo sapiens | UACC-62 | GI50 | 1757.92 | nM | None |
| Homo sapiens | Ubiquitin carboxyl-terminal hydrolase 2 | IC50 | 100000.0 | nM | 10.1016/j.ejmech.2020.112107 |
| Homo sapiens | Ubiquitin carboxyl-terminal hydrolase 2 | Kis | 349.0 | uM | 10.1016/j.ejmech.2020.112107 |
| Homo sapiens | UO-31 | GI50 | 6854.88 | nM | None |
| Homo sapiens | Vascular endothelial growth factor receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Vascular endothelial growth factor receptor 1 | Ki | nan | None | None |
| Homo sapiens | Vascular endothelial growth factor receptor 2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Vasoactive intestinal polypeptide receptor 1 | IC50 | nan | None | None |
| Homo sapiens | Vasoactive intestinal polypeptide receptor 1 | Ki | nan | None | None |
| Homo sapiens | Vasopressin V1a receptor | IC50 | nan | None | None |
| Homo sapiens | Vasopressin V1a receptor | Ki | nan | None | None |
| Homo sapiens | WIL2-NS | CC50 | 3000.0 | nM | 10.1016/j.ejmech.2011.06.018 |
| Homo sapiens | WIL2-NS | IC50 | 3000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| Homo sapiens | XF498 | GI50 | 5035.01 | nM | None |
| Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | 7.84 | % | 10.6019/CHEMBL4513141 |
| Leishmania amazonensis | Leishmania amazonensis | IC50 | 227000.0 | nM | 10.1016/j.ejmech.2006.10.014 |
| Leishmania chagasi | Leishmania chagasi | IC50 | 227000.0 | nM | 10.1016/j.ejmech.2006.10.014 |
| Mus musculus | B16 | IC50 | 0.8 | ug.mL-1 | 10.1021/np50112a002 |
| Mus musculus | Ehrlich | Activity | 0.3 | % | 10.1021/jm00222a009 |
| Mus musculus | Ehrlich | Activity | 0.7 | ml | 10.1021/jm00222a008 |
| Mus musculus | Ehrlich | Activity | 0.7 | ml | 10.1021/jm00222a009 |
| Mus musculus | Ehrlich | Activity | nan | None | 10.1021/jm00222a009 |
| Mus musculus | Ehrlich | Inhibition | 99.6 | % | 10.1021/jm00222a008 |
| Mus musculus | Ehrlich | Inhibition | 99.9 | % | 10.1021/np50077a010 |
| Mus musculus | Ehrlich | Survival | nan | None | 10.1021/jm00213a003 |
| Mus musculus | Ehrlich | Survival | nan | None | 10.1021/jm00222a008 |
| Mus musculus | Ehrlich | TGI | 99.4 | % | 10.1021/jm00213a003 |
| Mus musculus | Ehrlich | TGI | 99.6 | % | 10.1021/jm00222a009 |
| Mus musculus | J774 | IC50 | 0.5 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | J774 | IC50 | 3.0 | nM | 10.1021/np990231n |
| Mus musculus | J774 | IC50 | 3.6 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | J774 | IC50 | 61.0 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | J774.A1 | Activity | 27.86 | % | 10.1021/acs.jnatprod.0c01256 |
| Mus musculus | J774.A1 | Activity | nan | None | 10.1128/aac.01029-10 |
| Mus musculus | J774.A1 | IC50 | 0.0051 | ug.mL-1 | 10.1021/np800610p |
| Mus musculus | J774.A1 | IC50 | 3.0 | nM | 10.1021/np050493r |
| Mus musculus | J774.A1 | IC50 | 3.0 | nM | 10.1021/np060257w |
| Mus musculus | J774.A1 | IC50 | 3.0 | nM | 10.1021/np8000464 |
| Mus musculus | J774.A1 | Inhibition | 31.8 | % | 10.1021/np9002383 |
| Mus musculus | J774.A1 | Inhibition | 38.0 | % | 10.1021/np9002383 |
| Mus musculus | J774.A1 | Inhibition | 44.1 | % | 10.1021/np9002383 |
| Mus musculus | L1210 | IC50 | 20.0 | nM | 10.1021/jm00111a004 |
| Mus musculus | L1210 | IC50 | 24.0 | nM | 10.1021/jm00111a004 |
| Mus musculus | L1210 | Log CR | 0.6 | None | 10.1021/jm00169a014 |
| Mus musculus | Monoamine oxidase A | Activity | nan | None | 10.1021/jm800656v |
| Mus musculus | Monoamine oxidase B | Activity | nan | None | 10.1021/jm800656v |
| Mus musculus | Mus musculus | % | 0.3 | None | 10.1021/jm00139a017 |
| Mus musculus | Mus musculus | Activity | 0.7 | ml | 10.1021/jm00197a027 |
| Mus musculus | Mus musculus | Activity | nan | None | 10.1021/jm00197a027 |
| Mus musculus | Mus musculus | ascites volume | 0.2 | ml mouse-1 | 10.1021/jm00360a017 |
| Mus musculus | Mus musculus | ascrit | 0.7 | None | 10.1021/jm00177a012 |
| Mus musculus | Mus musculus | Inhibition | 96.3 | % | 10.1021/jm00360a017 |
| Mus musculus | Mus musculus | Inhibition | 99.6 | % | 10.1021/jm00139a017 |
| Mus musculus | Mus musculus | Inhibition | 99.6 | % | 10.1021/jm00197a027 |
| Mus musculus | Mus musculus | Inhibition | 99.9 | % | 10.1021/jm00177a012 |
| Mus musculus | Mus musculus | Mean hemagglutination titers | 3.4 | None | 10.1021/jm00136a008 |
| Mus musculus | Mus musculus | Mean hemagglutination titers | 4.1 | None | 10.1021/jm00136a008 |
| Mus musculus | Mus musculus | Mean hemagglutination titers | 7.2 | None | 10.1021/jm00136a008 |
| Mus musculus | Mus musculus | Mean hemagglutination titers | 7.5 | None | 10.1021/jm00136a008 |
| Mus musculus | Mus musculus | packed cell volume | 10.5 | % | 10.1021/jm00360a017 |
| Mus musculus | Mus musculus | permeability | 0.0038 | umol cm2/hr | 10.1016/j.bmcl.2006.03.061 |
| Mus musculus | Mus musculus | Suppression | 52.0 | % | 10.1021/jm00139a012 |
| Mus musculus | Mus musculus | Suppression | 63.0 | % | 10.1021/jm00139a012 |
| Mus musculus | Mus musculus | Survival after 10 days | 6.0 | None | 10.1021/jm00177a012 |
| Mus musculus | Mus musculus | Survivors | 16.0 | None | 10.1021/jm00360a017 |
| Mus musculus | Mus musculus | Survivors at day 9 | 6.0 | None | 10.1021/jm00139a017 |
| Mus musculus | Mus musculus | Volume | 0.7 | None | 10.1021/jm00139a017 |
| Mus musculus | Mus musculus | Volume of ascrit fluid | 0.3 | None | 10.1021/jm00177a012 |
| Mus musculus | Nitric oxide synthase, inducible | IC50 | nan | None | None |
| Mus musculus | Nitric oxide synthase, inducible | Ki | nan | None | None |
| Mus musculus | P388 | ED50 | 0.25 | ug ml-1 | 10.1021/np50100a013 |
| Mus musculus | P388 | ED50 | 0.7 | ug ml-1 | 10.1021/np50100a013 |
| Mus musculus | P388 | GI50 | 8892.01 | nM | None |
| Mus musculus | P388 | IC50 | 0.26 | ug.mL-1 | 10.1021/np50112a002 |
| Mus musculus | P388 | IC50 | 0.3 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | P388 | IC50 | 0.7 | ug.mL-1 | 10.1021/np50112a002 |
| Mus musculus | P388 | IC50 | 2.1 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | P388 | IC50 | 37.0 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | P388 | Survival | 12.0 | day | 10.1021/jm00222a008 |
| Mus musculus | P388 | Survival | 12.0 | day | 10.1021/jm00222a009 |
| Mus musculus | P388 | T/C | 148.0 | % | 10.1021/jm00222a009 |
| Mus musculus | P388 | T/C | 148.0 | None | 10.1021/jm00222a008 |
| Mus musculus | P388/ADR | GI50 | 19498.45 | nM | None |
| Mus musculus | S49 | EC50 | 8000.0 | nM | 10.1021/jm00193a012 |
| Mus musculus | S49 | EC50 | 1000000.0 | nM | 10.1021/jm00193a012 |
| Mus musculus | S49 | GI | nan | None | 10.1021/jm00193a012 |
| Mus musculus | Solute carrier family 22 member 8 | Km | 4010.0 | nM | 10.1124/dmd.32.5.479 |
| Mus musculus | WEHI-164 | IC50 | 0.0025 | ug.mL-1 | 10.1021/np800610p |
| Mus musculus | WEHI-164 | IC50 | 1.3 | ug.mL-1 | 10.1021/np000281o |
| Mus musculus | WEHI-164 | IC50 | 1.3 | ug.mL-1 | 10.1021/np000438c |
| Mus musculus | WEHI-164 | IC50 | 2.7 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | WEHI-164 | IC50 | 15.0 | nM | 10.1021/np050493r |
| Mus musculus | WEHI-164 | IC50 | 15.0 | nM | 10.1021/np060257w |
| Mus musculus | WEHI-164 | IC50 | 15.0 | nM | 10.1021/np8000464 |
| Mus musculus | WEHI-164 | IC50 | 17.0 | nM | 10.1021/np990231n |
| Mus musculus | WEHI-164 | IC50 | 42.0 | ug.mL-1 | 10.1021/np960657r |
| Mus musculus | WEHI-164 | IC50 | 83.0 | ug.mL-1 | 10.1021/np960657r |
| Mycobacterium avium | Mycobacterium avium | Activity | 8.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium | Mycobacterium avium | Activity | 16.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium | Mycobacterium avium | Activity | 32.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium | Mycobacterium avium | Activity | 64.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | Activity | 1.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | Activity | 2.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | Activity | 4.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | Activity | 8.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | Activity | 16.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | Activity | 32.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | Activity | nan | None | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | log10CFU/ml | 3.19 | None | 10.1128/aac.00678-07 |
| Mycobacterium avium subsp. paratuberculosis | Mycobacterium avium subsp. paratuberculosis | log10CFU/ml | 3.87 | None | 10.1128/aac.00678-07 |
| Mycobacterium tuberculosis | Purine nucleoside phosphorylase | Kd | 79432.82 | nM | 10.1016/j.bmc.2010.05.009 |
| Mycolicibacterium phlei | Mycolicibacterium phlei | Activity | 1.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycolicibacterium phlei | Mycolicibacterium phlei | Activity | 16.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Mycolicibacterium smegmatis | Mycolicibacterium smegmatis | Activity | 128.0 | ug ml-1 | 10.1128/aac.00678-07 |
| Oryctolagus cuniculus | Angiotensin-converting enzyme | IC50 | nan | None | None |
| Oryctolagus cuniculus | Angiotensin-converting enzyme | Ki | nan | None | None |
| Oryctolagus cuniculus | Arachidonate 15-lipoxygenase | IC50 | nan | None | None |
| Oryctolagus cuniculus | Arachidonate 15-lipoxygenase | Ki | nan | None | None |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 1300.0 | nM | 10.1021/jm061012j |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 2000.0 | nM | 10.1021/jm061012j |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 104.2 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 4147.5 | nM | None |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | 11.75 | % | 10.6019/CHEMBL4513141 |
| Rattus norvegicus | Aldose reductase | IC50 | nan | None | None |
| Rattus norvegicus | Aldose reductase | Ki | nan | None | None |
| Rattus norvegicus | Alpha-1a adrenergic receptor | IC50 | nan | None | None |
| Rattus norvegicus | Alpha-1a adrenergic receptor | Ki | nan | None | None |
| Rattus norvegicus | Alpha-1b adrenergic receptor | IC50 | nan | None | None |
| Rattus norvegicus | Alpha-1b adrenergic receptor | Ki | nan | None | None |
| Rattus norvegicus | Androgen Receptor | IC50 | nan | None | None |
| Rattus norvegicus | Androgen Receptor | Ki | nan | None | None |
| Rattus norvegicus | C6 | IC50 | 30.2 | ug.mL-1 | 10.1021/np000281o |
| Rattus norvegicus | Glycine receptor | IC50 | nan | None | None |
| Rattus norvegicus | Glycine receptor | Ki | nan | None | None |
| Rattus norvegicus | Insulin receptor | IC50 | nan | None | None |
| Rattus norvegicus | Insulin receptor | Ki | nan | None | None |
| Rattus norvegicus | Nitric-oxide synthase, brain | IC50 | nan | None | None |
| Rattus norvegicus | Nitric-oxide synthase, brain | Ki | nan | None | None |
| Rattus norvegicus | Rattus norvegicus | ALB | 39000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 41700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 43300.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALB | 44000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 341.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 364.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 384.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALP | 420.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 58.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 61.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 61.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ALT | 66.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 75.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 83.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 91.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | AST | 105.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASO | 0.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BASOLE | 0.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 1.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BILI | 2.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 106.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 120.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 130.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | BUN | 150.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 99.0 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 99.33 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHLORIDE | 100.33 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 730.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 736.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CHOL | 773.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 175.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 274.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 601.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CK | 602.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 25000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 28000000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 29330000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CO2 | 30330000.0 | nM | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 1.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 1.5 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 1.6 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | CREAT | 2.2 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | ED50 | 20.0 | mg kg-1 (day in diet)-1 | 10.1021/jm00127a013 |
| Rattus norvegicus | Rattus norvegicus | EOS | 0.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 80.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 96.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOS | 128.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | EOSLE | 0.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1536.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1630.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1640.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | GLUC | 1643.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 31.73 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 34.93 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 36.7 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HCT | 40.73 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 128700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 136000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 143000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | HGB | 154700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | Highest nontoxic dose | 20.0 | mg kg-1 (day in diet)-1 | 10.1021/jm00127a013 |
| Rattus norvegicus | Rattus norvegicus | LD50 | 25.0 | mg kg-1 (day in diet)-1 | 10.1021/jm00127a013 |
| Rattus norvegicus | Rattus norvegicus | LDH | 111.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 112.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 169.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LDH | 320.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 11.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 12.33 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 12.67 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LIPASE | 13.0 | U.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 6679.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 10655.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 12020.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYM | 12203.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 88.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 90.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | LYMLE | 91.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 24.1 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 24.33 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 24.83 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCH | 25.3 | pg | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 380000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 389700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 390000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCHC | 406000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 62.3 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 62.4 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 63.4 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MCV | 63.73 | fL | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 48.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 203.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 204.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONO | 205.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 0.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 1.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | MONOLE | 2.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 6.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 7.0 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 8.67 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTLE | 9.33 | % | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 481.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 927.33 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 1066.67 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | NEUTSG | 1366.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 101.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 110.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 110.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PHOS | 119.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 972000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1127000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1148670.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PLAT | 1431670.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.32 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.41 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 6.85 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | POTASSIUM | 7.18 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 56000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 58000.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 59700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | PROT | 60700.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5090000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5620000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 5760000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBC | 6410000.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBCNUC | 0.0 | /100WBC | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | RBCNUC | 0.33 | /100WBC | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 141.03 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 142.27 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 142.6 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | SODIUM | 142.8 | mEq.L-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | Tissue Severity Score | nan | None | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 11.3 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 14.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 15.0 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | URATE | 15.7 | ug.mL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 7370.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 11870.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 13230.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Rattus norvegicus | WBC | 13900.0 | cells.uL-1 | 10.6019/CHEMBL3885881 |
| Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | IC50 | nan | None | None |
| Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Ki | nan | None | None |
| Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | IC50 | nan | None | None |
| Rattus norvegicus | Serotonin 1b (5-HT1b) receptor | Ki | nan | None | None |
| Rattus norvegicus | Solute carrier family 22 member 8 | Activity | 8.67 | % | 10.1097/00004647-200304000-00007 |
| Rattus norvegicus | Solute carrier family 22 member 8 | Activity | 19.1 | % | 10.1046/j.1471-4159.2002.01108.x |
| Rattus norvegicus | UDP-glucose 6-dehydrogenase | Inhibition | 12.0 | % | 10.1039/C8MD00463C |
| Rattus norvegicus | UDP-glucose 6-dehydrogenase | Inhibition | 19.0 | % | 10.1039/C8MD00463C |
| Rattus norvegicus | UDP-glucose 6-dehydrogenase | Inhibition | 26.0 | % | 10.1039/C8MD00463C |
| Rattus norvegicus | UDP-glucose 6-dehydrogenase | Inhibition | 28.0 | % | 10.1039/C8MD00463C |
| Rattus norvegicus | UDP-glucose 6-dehydrogenase | Inhibition | nan | % | 10.1039/C8MD00463C |
| Rattus norvegicus | UDP-glucose 6-dehydrogenase | Ki | 288000.0 | nM | 10.1039/C8MD00463C |
| Rattus norvegicus | UDP-glucuronosyltransferase 1A1 | Inhibition | nan | % | 10.1039/C8MD00463C |
| Rattus norvegicus | UDP-glucuronosyltransferase 1A1 | Ki | 100000.0 | nM | 10.1039/C8MD00463C |
| Schistosoma mansoni | Thioredoxin glutathione reductase | Potency | 15848.9 | nM | None |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | -11.49 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Hit score | 0.2212 | None | 10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.14 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 3.56 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition index | 0.04283 | None | 10.1101/2020.04.03.023846 |
| Staphylococcus aureus | Staphylococcus aureus | Inhibition | 22.75 | % | 10.6019/CHEMBL4513141 |
| Streptococcus pyogenes | UDP-glucose 6-dehydrogenase | Ki | 111000.0 | nM | 10.1039/C9MD00010K |
| Streptococcus pyogenes | UDP-glucose 6-dehydrogenase | Ki | 288000.0 | nM | 10.1039/C9MD00010K |
| None | ADMET | CL | 15.0 | mL.min-1.kg-1 | 10.1124/dmd.108.020479 |
| None | ADMET | delta logD | -0.72 | None | 10.1021/jm0000564 |
| None | ADMET | F | 20.0 | % | 10.1021/jm0000564 |
| None | ADMET | LD50 | 0.28 | mM | 10.1021/jm00370a022 |
| None | ADMET | LD50 | 0.35 | mM | 10.1021/jm00370a022 |
| None | ADMET | LD50 | 0.76 | mM | 10.1021/jm00370a022 |
| None | ADMET | MRT | 1.11 | hr | 10.1124/dmd.108.020479 |
| None | ADMET | Stability | 1.0 | yr | 10.1136/gut.39.1.63 |
| None | ADMET | Stability | 4.0 | hr | 10.1136/gut.39.1.63 |
| None | ADMET | Stability | 5.0 | hr | 10.1136/gut.39.1.63 |
| None | ADMET | Stability | 30.0 | hr | 10.1136/gut.39.1.63 |
| None | ADMET | T1/2 | 1.0 | hr | 10.1124/dmd.108.020479 |
| None | ADMET | Vdss | 1.0 | L.kg-1 | 10.1124/dmd.108.020479 |
| None | Hepatotoxicity | Alkaline Phosphatase Increase - Activity Score | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | Alkaline Phosphatase Increase - Index Value | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | Alkaline Phosphatase Increase - Number of Reports | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | Composite Activity - Active | 2.0 | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | Composite Activity - Marginal | 0.0 | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | Composite Activity - Score | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | GGT Increase - Activity Score | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | GGT Increase - Index Value | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | GGT Increase - Number of Reports | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx1000865 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx900326k |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1124/dmd.110.035113 |
| None | Hepatotoxicity | HepSE_bilirubinemia | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholecystitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholelithiasis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cirrhosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_Combined Scores | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_elevated liver function tests | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic failure | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic necrosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatomegaly | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_jaundice | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver disease | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver fatty | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver function tests abnormal | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | LDH Increase - Activity Score | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | LDH Increase - Index Value | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | LDH Increase - Number of Reports | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | LTKB_BD DILI severity score | 8.0 | None | 10.1016/j.drudis.2011.05.007 |
| None | Hepatotoxicity | SGOT Increase - Activity Score | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | SGOT Increase - Index Value | 4.4 | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | SGOT Increase - Number of Reports | 4.0 | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | SGPT Increase - Activity Score | nan | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | SGPT Increase - Index Value | 5.2 | None | 10.2174/1570163043334794 |
| None | Hepatotoxicity | SGPT Increase - Number of Reports | 4.0 | None | 10.2174/1570163043334794 |
| None | NON-PROTEIN TARGET | Activity | nan | None | 10.1016/j.ejmech.2009.07.020 |
| None | NON-PROTEIN TARGET | ED50 | 0.76 | ug ml-1 | 10.1021/np50100a013 |
| None | NON-PROTEIN TARGET | Fu | 0.85 | None | 10.1124/dmd.108.020479 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (acute) | 4.9 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (animal toxicity known) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (benign tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (granulomatous hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (mechanism) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 13.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 53.0 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (time to onset) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | IC50 | 0.79 | ug.mL-1 | 10.1021/np50112a002 |
| None | NON-PROTEIN TARGET | IC50 | 2450.0 | nM | 10.1124/dmd.110.033613 |
| None | NON-PROTEIN TARGET | IC50 | 2630.0 | nM | 10.1124/dmd.110.033613 |
| None | NON-PROTEIN TARGET | IC50 | 4090.0 | nM | 10.1124/dmd.110.033613 |
| None | NON-PROTEIN TARGET | IC50 | 4700.0 | nM | 10.1016/j.ejmech.2009.07.020 |
| None | NON-PROTEIN TARGET | IC50 | 6120.0 | nM | 10.1124/dmd.110.033613 |
| None | NON-PROTEIN TARGET | IC50 | 6390.0 | nM | 10.1124/dmd.110.033613 |
| None | NON-PROTEIN TARGET | IC50 | 9690.0 | nM | 10.1124/dmd.110.033613 |
| None | NON-PROTEIN TARGET | IC50 | 11070.0 | nM | 10.1124/dmd.110.033613 |
| None | NON-PROTEIN TARGET | IC50 | 100000.0 | nM | 10.1016/j.ejmech.2006.11.013 |
| None | NON-PROTEIN TARGET | IC50 | 188000.0 | nM | 10.1016/j.ejmech.2009.07.020 |
| None | NON-PROTEIN TARGET | IC50 | 200000.0 | nM | 10.1016/j.ejmech.2008.03.027 |
| None | NON-PROTEIN TARGET | Potency | 1.4 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 135.5 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 3755.3 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 14950.2 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 18821.2 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 21671.2 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 30611.4 | nM | None |
| None | NON-PROTEIN TARGET | TIME | 3.0 | hr | 10.1016/j.ejmech.2009.07.020 |
| None | NON-PROTEIN TARGET | TIME | 6.767 | hr | 10.1016/j.ejmech.2009.07.020 |
| None | No relevant target | LogD | -1.12 | None | 10.1021/jm0000564 |
| None | No relevant target | LogD | 0.01 | None | 10.1021/jm00169a014 |
| None | No relevant target | log K | -1.75 | None | 10.1016/j.bmcl.2006.03.061 |
| None | No relevant target | LogP | -0.4 | None | 10.1016/j.ejmech.2009.12.043 |
| None | No relevant target | pKa | 7.6 | None | 10.1021/jm0000564 |
| None | No relevant target | Solubility | 20000.0 | nM | 10.1016/j.bmcl.2006.03.061 |
| None | No relevant target | Solubility | 1000000.0 | nM | 10.1016/j.ejmech.2014.06.078 |
| None | No relevant target | Solubility | 1120000.0 | nM | 10.1016/j.bmcl.2006.03.061 |
| None | Phospholipidosis | Phospholipidosis | nan | None | 10.1080/15376510701857262 |
| None | Radical scavenging activity | IC50 | 65000.0 | nM | 10.1016/j.ejmech.2009.07.020 |
| None | Unchecked | Ac50 | 0.4467 | uM | None |
| None | Unchecked | Ac50 | 1.122 | uM | None |
| None | Unchecked | Ac50 | 3.548 | uM | None |
| None | Unchecked | AC50 | 450.0 | nM | None |
| None | Unchecked | AC50 | 1122.0 | nM | None |
| None | Unchecked | AC50 | 3548.1 | nM | None |
| None | Unchecked | Activity | 8.68 | % | 10.1016/j.ejmech.2008.03.027 |
| None | Unchecked | Activity | 9.7 | % | 10.1016/j.ejmech.2008.03.027 |
| None | Unchecked | Activity | 9.78 | % | 10.1016/j.ejmech.2008.03.027 |
| None | Unchecked | Activity | nan | None | 10.1021/jm061012j |
| None | Unchecked | CC50 | 40000.0 | nM | None |
| None | Unchecked | EC50 | 5346.0 | nM | None |
| None | Unchecked | EC50 | 11640.0 | nM | None |
| None | Unchecked | EC50 | 12994.0 | nM | None |
| None | Unchecked | Hepatotoxicity (acute) | 30.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (association with vascular disease) | 2.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (choleostasis) | 15.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (chronic liver disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cirrhosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (comment) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cytolytic) | 15.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (malignant tumour) | 3.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (severe hepatitis) | 5.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (steatosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (successful reintroduction) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | IC50 | 259.1 | nM | None |
| None | Unchecked | IC50 | 259.81 | nM | None |
| None | Unchecked | IC50 | 634.55 | nM | None |
| None | Unchecked | IC50 | 659.1 | nM | None |
| None | Unchecked | IC50 | 914.9 | nM | None |
| None | Unchecked | IC50 | 1035.79 | nM | None |
| None | Unchecked | IC50 | 1298.6 | nM | None |
| None | Unchecked | IC50 | 1418.93 | nM | None |
| None | Unchecked | IC50 | 3080.0 | nM | None |
| None | Unchecked | IC50 | 3320.0 | nM | None |
| None | Unchecked | IC50 | 10000.0 | nM | None |
| None | Unchecked | IC50 | 20000.0 | nM | None |
| None | Unchecked | IC50 | nan | None | None |
| None | Unchecked | Inhibition | nan | % | 10.1016/j.bmcl.2014.01.014 |
| None | Unchecked | Inhibition | nan | % | 10.1039/C9MD00010K |
| None | Unchecked | Kcat | 2.4 | /s | 10.1021/acs.jmedchem.0c02184 |
| None | Unchecked | Ki | nan | None | None |
| None | Unchecked | Km | 20.0 | nM | 10.1021/jm061012j |
| None | Unchecked | Km | 1600.0 | nM | 10.1021/jm061012j |
| None | Unchecked | Km | 41000.0 | nM | 10.1021/acs.jmedchem.0c02184 |
| None | Unchecked | Potency | 19.1 | nM | None |
| None | Unchecked | Potency | 67.9 | nM | None |
| None | Unchecked | Potency | 605.4 | nM | None |
| None | Unchecked | Potency | 679.2 | nM | None |
| None | Unchecked | Potency | 2818.4 | nM | None |
| None | Unchecked | Potency | 2909.3 | nM | None |
| None | Unchecked | Potency | 3162.3 | nM | None |
| None | Unchecked | Potency | 12589.3 | nM | None |
| None | Unchecked | Potency | 14125.4 | nM | None |
| None | Unchecked | Potency | 17782.8 | nM | None |
| None | Unchecked | Potency | 21479.6 | nM | None |
| None | Unchecked | Potency | 25118.9 | nM | None |
| None | Unchecked | Potency | 67924.5 | nM | None |
| None | Unchecked | Ratio | 1.18 | None | 10.1021/jm00111a004 |
